Orgiazzi J - Search Results

1

Orgiazzi J. Orgiazzi J. Endocrinol Metab Clin North Am. 1987 Jun;16(2):365-89. Endocrinol Metab Clin North Am. 1987. PMID: 2446867 Review.

2

Anti-TSH receptor antibodies in clinical practice.

Orgiazzi J. Orgiazzi J. Endocrinol Metab Clin North Am. 2000 Jun;29(2):339-55, vii. doi: 10.1016/s0889-8529(05)70135-3. Endocrinol Metab Clin North Am. 2000. PMID: 10874533 Review.

3

Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration.

Allannic H, Fauchet R, Orgiazzi J, Madec AM, Genetet B, Lorcy Y, Le Guerrier AM, Delambre C, Derennes V. Allannic H, et al. Among authors: orgiazzi j. J Clin Endocrinol Metab. 1990 Mar;70(3):675-9. doi: 10.1210/jcem-70-3-675. J Clin Endocrinol Metab. 1990. PMID: 1689737 Clinical Trial.

4

Treatment of adult Graves' disease.

Corvilain B, Hamy A, Brunaud L, Borson-Chazot F, Orgiazzi J, Bensalem Hachmi L, Semrouni M, Rodien P, Lussey-Lepoutre C. Corvilain B, et al. Among authors: orgiazzi j. Ann Endocrinol (Paris). 2018 Dec;79(6):618-635. doi: 10.1016/j.ando.2018.08.003. Epub 2018 Aug 16. Ann Endocrinol (Paris). 2018. PMID: 30193753 Review.

5

[The treatment of Graves' disease: current views and controversies].

Orgiazzi J. Orgiazzi J. Presse Med. 2011 Dec;40(12 Pt 1):1155-62. doi: 10.1016/j.lpm.2011.09.012. Epub 2011 Nov 9. Presse Med. 2011. PMID: 22078090 Review. French.

6

Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves' disease.

Bohbot NL, Young J, Orgiazzi J, Buffet C, François M, Bernard-Chabert B, Lukas-Croisier C, Delemer B. Bohbot NL, et al. Among authors: orgiazzi j. Eur J Endocrinol. 2006 Mar;154(3):367-72. doi: 10.1530/eje.1.02104. Eur J Endocrinol. 2006. PMID: 16498048

7

Reduction of the risk of relapse after withdrawal of medical therapy for Graves' disease.

Orgiazzi J, Madec AM. Orgiazzi J, et al. Thyroid. 2002 Oct;12(10):849-53. doi: 10.1089/105072502761016467. Thyroid. 2002. PMID: 12487766 Review.

8

Lasting remissions in patients treated for Graves' hyperthyroidism with propranolol alone: a pattern of spontaneous evolution of the disease.

Codaccioni JL, Orgiazzi J, Blanc P, Pugeat M, Roulier R, Carayon P. Codaccioni JL, et al. Among authors: orgiazzi j. J Clin Endocrinol Metab. 1988 Oct;67(4):656-62. doi: 10.1210/jcem-67-4-656. J Clin Endocrinol Metab. 1988. PMID: 3417846

9

Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.

Laurberg P, Bournaud C, Karmisholt J, Orgiazzi J. Laurberg P, et al. Among authors: orgiazzi j. Eur J Endocrinol. 2009 Jan;160(1):1-8. doi: 10.1530/EJE-08-0663. Epub 2008 Oct 10. Eur J Endocrinol. 2009. PMID: 18849306 Review.

10

Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study.

Wémeau JL, Caron P, Beckers A, Rohmer V, Orgiazzi J, Borson-Chazot F, Nocaudie M, Perimenis P, Bisot-Locard S, Bourdeix I, Dejager S. Wémeau JL, et al. Among authors: orgiazzi j. J Clin Endocrinol Metab. 2005 Feb;90(2):841-8. doi: 10.1210/jc.2004-1334. Epub 2004 Nov 23. J Clin Endocrinol Metab. 2005. PMID: 15562016 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters